How much is PAhR Therapeutics worth in 2026?

PAhR Therapeutics has a current valuation of N/A based on their Seed Round round and secondary market data.

How much funding has PAhR Therapeutics raised?

PAhR Therapeutics has raised N/A in total funding across 1 funding rounds.

PAhR Therapeutics

Drug Discovery

PAhR Therapeutics valuation and funding history | Last updated: July 28, 2025 | 1 funding rounds

Current Valuation

N/A

As of July 28, 2025

Total Funding Raised

N/A

Across 1 round

Last Round

Seed Round

$14.0M

Last Funding

Jul 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
July 28, 2025	Seed Round	$14.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

PAhR Therapeutics is currently valued at N/A as of July 28, 2025.

Track PAhR Therapeutics Valuation Updates

Get notified when PAhR Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for PAhR Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock PAhR Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is PAhR Therapeutics Worth in 2026?

PAhR Therapeutics is a leading private company in the Drug Discovery sector. Track PAhR Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How PAhR Therapeutics Valuation is Determined

Private company valuations like PAhR Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.